Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 14 | 2023 | 397 | 3.880 |
Why?
|
| Electroencephalography | 20 | 2023 | 709 | 2.340 |
Why?
|
| Epilepsy, Temporal Lobe | 12 | 2023 | 122 | 2.270 |
Why?
|
| Visual Cortex | 12 | 2022 | 251 | 2.180 |
Why?
|
| Neurocysticercosis | 4 | 2021 | 7 | 2.110 |
Why?
|
| Hippocampus | 9 | 2022 | 442 | 1.960 |
Why?
|
| Seizures | 13 | 2023 | 297 | 1.770 |
Why?
|
| Laser Therapy | 5 | 2023 | 142 | 1.460 |
Why?
|
| Sleep | 9 | 2022 | 444 | 1.430 |
Why?
|
| Brain Mapping | 8 | 2012 | 548 | 1.260 |
Why?
|
| Calcinosis | 3 | 2021 | 224 | 1.220 |
Why?
|
| Flavoproteins | 4 | 2011 | 25 | 1.080 |
Why?
|
| Photic Stimulation | 11 | 2019 | 493 | 1.040 |
Why?
|
| Brain | 10 | 2023 | 2216 | 1.020 |
Why?
|
| Machado-Joseph Disease | 1 | 2023 | 8 | 0.930 |
Why?
|
| Models, Neurological | 4 | 2011 | 405 | 0.870 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2023 | 73 | 0.860 |
Why?
|
| Atrophy | 3 | 2021 | 117 | 0.770 |
Why?
|
| Space Perception | 4 | 2008 | 115 | 0.760 |
Why?
|
| Synapses | 4 | 2009 | 265 | 0.720 |
Why?
|
| Anticonvulsants | 3 | 2020 | 126 | 0.680 |
Why?
|
| Cysticercus | 1 | 2018 | 2 | 0.680 |
Why?
|
| Antigens, Helminth | 1 | 2018 | 22 | 0.670 |
Why?
|
| Orientation | 4 | 2008 | 119 | 0.660 |
Why?
|
| Frontal Lobe | 1 | 2018 | 130 | 0.630 |
Why?
|
| Scalp | 4 | 2022 | 72 | 0.600 |
Why?
|
| Neural Pathways | 3 | 2010 | 308 | 0.580 |
Why?
|
| Cognition | 1 | 2020 | 570 | 0.540 |
Why?
|
| Humans | 48 | 2023 | 86643 | 0.530 |
Why?
|
| Piracetam | 1 | 2015 | 8 | 0.530 |
Why?
|
| Visual Perception | 5 | 2022 | 319 | 0.530 |
Why?
|
| Neuronal Plasticity | 6 | 2023 | 187 | 0.520 |
Why?
|
| Long QT Syndrome | 1 | 2015 | 34 | 0.520 |
Why?
|
| Muscle, Skeletal | 2 | 2022 | 449 | 0.510 |
Why?
|
| Encephalitis, Varicella Zoster | 1 | 2014 | 6 | 0.510 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2014 | 8 | 0.510 |
Why?
|
| Visual Pathways | 4 | 2011 | 152 | 0.510 |
Why?
|
| Propylene Glycols | 1 | 2014 | 30 | 0.510 |
Why?
|
| Neurons | 6 | 2011 | 1546 | 0.500 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2014 | 2 | 0.500 |
Why?
|
| Epilepsy, Generalized | 3 | 2023 | 37 | 0.490 |
Why?
|
| Sphingosine | 1 | 2014 | 71 | 0.490 |
Why?
|
| Lasers | 3 | 2023 | 106 | 0.490 |
Why?
|
| Cats | 8 | 2011 | 303 | 0.490 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 140 | 0.470 |
Why?
|
| Geniculate Bodies | 2 | 2011 | 140 | 0.470 |
Why?
|
| Functional Laterality | 4 | 2019 | 201 | 0.450 |
Why?
|
| Aging | 2 | 2016 | 691 | 0.450 |
Why?
|
| Hair Cells, Auditory | 4 | 1996 | 23 | 0.430 |
Why?
|
| Amyloid Neuropathies, Familial | 2 | 2022 | 25 | 0.420 |
Why?
|
| Drug Resistant Epilepsy | 4 | 2023 | 42 | 0.410 |
Why?
|
| Auditory Cortex | 2 | 2022 | 58 | 0.400 |
Why?
|
| Female | 29 | 2021 | 44532 | 0.400 |
Why?
|
| Stereotaxic Techniques | 3 | 2020 | 69 | 0.370 |
Why?
|
| Motion Perception | 2 | 2008 | 105 | 0.370 |
Why?
|
| Lennox Gastaut Syndrome | 2 | 2020 | 14 | 0.360 |
Why?
|
| Animals | 23 | 2018 | 26582 | 0.360 |
Why?
|
| Cardiomyopathies | 2 | 2022 | 240 | 0.360 |
Why?
|
| Corpus Callosum | 2 | 2020 | 56 | 0.350 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 977 | 0.350 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 132 | 0.330 |
Why?
|
| Middle Aged | 19 | 2021 | 25028 | 0.330 |
Why?
|
| Olfactory Pathways | 1 | 2008 | 23 | 0.320 |
Why?
|
| Olfactory Bulb | 1 | 2008 | 40 | 0.320 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 79 | 0.310 |
Why?
|
| Odorants | 1 | 2008 | 70 | 0.310 |
Why?
|
| Smell | 1 | 2008 | 109 | 0.300 |
Why?
|
| Dominance, Cerebral | 3 | 2005 | 66 | 0.290 |
Why?
|
| Prone Position | 2 | 2017 | 56 | 0.290 |
Why?
|
| Thalamus | 2 | 2023 | 132 | 0.280 |
Why?
|
| Male | 24 | 2021 | 40965 | 0.280 |
Why?
|
| Action Potentials | 5 | 2011 | 573 | 0.280 |
Why?
|
| Saccule and Utricle | 2 | 1996 | 19 | 0.270 |
Why?
|
| Presynaptic Terminals | 2 | 1996 | 40 | 0.270 |
Why?
|
| Electrocorticography | 3 | 2020 | 37 | 0.260 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2017 | 182 | 0.260 |
Why?
|
| Auditory Perception | 3 | 2022 | 96 | 0.260 |
Why?
|
| Adult | 17 | 2021 | 25648 | 0.250 |
Why?
|
| Beauty | 1 | 2023 | 8 | 0.240 |
Why?
|
| Glycine | 1 | 2003 | 92 | 0.230 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 83 | 0.230 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1805 | 0.220 |
Why?
|
| Neural Inhibition | 1 | 2003 | 97 | 0.220 |
Why?
|
| Memory Consolidation | 1 | 2022 | 14 | 0.220 |
Why?
|
| Young Adult | 10 | 2020 | 5976 | 0.220 |
Why?
|
| Central Nervous System | 1 | 2003 | 151 | 0.220 |
Why?
|
| Deep Brain Stimulation | 1 | 2023 | 54 | 0.220 |
Why?
|
| Fluorescence | 4 | 2011 | 102 | 0.220 |
Why?
|
| Mononeuropathies | 1 | 2022 | 8 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3362 | 0.200 |
Why?
|
| Cerebellum | 1 | 2023 | 247 | 0.200 |
Why?
|
| Calcium | 2 | 1996 | 1156 | 0.200 |
Why?
|
| Death, Sudden | 2 | 2019 | 40 | 0.200 |
Why?
|
| Reaction Time | 3 | 2007 | 309 | 0.200 |
Why?
|
| Speech Perception | 1 | 2021 | 71 | 0.200 |
Why?
|
| Electromagnetic Phenomena | 1 | 2020 | 18 | 0.190 |
Why?
|
| Homeostasis | 1 | 2023 | 409 | 0.190 |
Why?
|
| Entropy | 1 | 2020 | 38 | 0.190 |
Why?
|
| Epilepsies, Partial | 1 | 2020 | 42 | 0.190 |
Why?
|
| Computers | 1 | 2020 | 112 | 0.190 |
Why?
|
| Theta Rhythm | 1 | 2020 | 27 | 0.190 |
Why?
|
| Contrast Sensitivity | 1 | 2000 | 69 | 0.180 |
Why?
|
| Embryonic Development | 1 | 2020 | 74 | 0.180 |
Why?
|
| Sleep Apnea, Central | 1 | 2019 | 14 | 0.180 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1999 | 11 | 0.180 |
Why?
|
| Neuronavigation | 1 | 2019 | 21 | 0.180 |
Why?
|
| Fourier Analysis | 2 | 2010 | 125 | 0.170 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2019 | 37 | 0.170 |
Why?
|
| Brain Waves | 1 | 2019 | 32 | 0.170 |
Why?
|
| Biomarkers | 3 | 2022 | 1718 | 0.170 |
Why?
|
| Aged | 8 | 2021 | 18415 | 0.170 |
Why?
|
| Implantable Neurostimulators | 1 | 2018 | 12 | 0.170 |
Why?
|
| Evoked Potentials, Visual | 1 | 2019 | 87 | 0.160 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 244 | 0.160 |
Why?
|
| Electrodes | 1 | 2018 | 78 | 0.160 |
Why?
|
| Limbic Encephalitis | 1 | 2018 | 11 | 0.160 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 32 | 0.160 |
Why?
|
| Retrospective Studies | 9 | 2023 | 8489 | 0.160 |
Why?
|
| Sclerosis | 1 | 2017 | 28 | 0.160 |
Why?
|
| Encephalitis | 1 | 2018 | 104 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2018 | 113 | 0.150 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2019 | 237 | 0.150 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 223 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 263 | 0.150 |
Why?
|
| Delta Rhythm | 1 | 2016 | 19 | 0.150 |
Why?
|
| Rana catesbeiana | 5 | 1996 | 11 | 0.150 |
Why?
|
| Vital Capacity | 1 | 2016 | 64 | 0.140 |
Why?
|
| Hair Cells, Vestibular | 1 | 1996 | 17 | 0.140 |
Why?
|
| Electromyography | 1 | 2017 | 183 | 0.140 |
Why?
|
| Calcium Channels | 2 | 1996 | 182 | 0.140 |
Why?
|
| Arm | 1 | 2017 | 91 | 0.140 |
Why?
|
| POEMS Syndrome | 1 | 2016 | 2 | 0.140 |
Why?
|
| Primary Dysautonomias | 1 | 2016 | 6 | 0.140 |
Why?
|
| Acoustic Stimulation | 3 | 2022 | 130 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 102 | 0.140 |
Why?
|
| Gastrostomy | 1 | 2016 | 69 | 0.140 |
Why?
|
| Receptors, Presynaptic | 1 | 1996 | 4 | 0.140 |
Why?
|
| Rural Population | 1 | 2016 | 136 | 0.140 |
Why?
|
| Antibodies | 1 | 2018 | 350 | 0.140 |
Why?
|
| Exocytosis | 1 | 1996 | 108 | 0.130 |
Why?
|
| ERG1 Potassium Channel | 1 | 2015 | 14 | 0.130 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2015 | 26 | 0.130 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2014 | 29 | 0.130 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2014 | 10 | 0.130 |
Why?
|
| Video Recording | 3 | 2020 | 190 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2016 | 678 | 0.130 |
Why?
|
| Point Mutation | 1 | 2015 | 246 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1268 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2023 | 7993 | 0.110 |
Why?
|
| Mice | 5 | 2012 | 11352 | 0.110 |
Why?
|
| Risk Factors | 3 | 2020 | 5417 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2015 | 478 | 0.110 |
Why?
|
| Time Factors | 4 | 2019 | 5210 | 0.110 |
Why?
|
| Membrane Potentials | 2 | 2009 | 435 | 0.110 |
Why?
|
| Prealbumin | 2 | 2022 | 34 | 0.110 |
Why?
|
| Electrophysiology | 2 | 2008 | 401 | 0.110 |
Why?
|
| Adolescent | 6 | 2020 | 8981 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3640 | 0.110 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2012 | 28 | 0.110 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 989 | 0.110 |
Why?
|
| Potassium Channels | 1 | 1994 | 340 | 0.110 |
Why?
|
| Heart | 1 | 2015 | 539 | 0.110 |
Why?
|
| Xanthenes | 3 | 1996 | 23 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 1673 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2018 | 2767 | 0.100 |
Why?
|
| Aniline Compounds | 3 | 1996 | 55 | 0.100 |
Why?
|
| Psychophysics | 1 | 2011 | 80 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 73 | 0.100 |
Why?
|
| Neocortex | 1 | 2012 | 95 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1961 | 0.100 |
Why?
|
| Wakefulness | 3 | 2020 | 134 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 425 | 0.090 |
Why?
|
| Retinal Ganglion Cells | 1 | 2010 | 66 | 0.090 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2009 | 14 | 0.090 |
Why?
|
| Temporal Lobe | 2 | 2022 | 172 | 0.090 |
Why?
|
| Glutamates | 1 | 2009 | 89 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 78 | 0.080 |
Why?
|
| Valine | 1 | 2009 | 69 | 0.080 |
Why?
|
| Neuropil | 1 | 2008 | 7 | 0.080 |
Why?
|
| Aldehydes | 1 | 2008 | 17 | 0.080 |
Why?
|
| Sensory Thresholds | 1 | 2008 | 54 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 396 | 0.080 |
Why?
|
| Retinoscopy | 1 | 2007 | 2 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2009 | 510 | 0.080 |
Why?
|
| Child | 2 | 2020 | 6927 | 0.080 |
Why?
|
| Somatosensory Cortex | 1 | 2009 | 129 | 0.070 |
Why?
|
| Perception | 1 | 2008 | 168 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 222 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 1047 | 0.070 |
Why?
|
| Sensory Deprivation | 2 | 2012 | 31 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2207 | 0.070 |
Why?
|
| Linear Models | 1 | 2007 | 421 | 0.070 |
Why?
|
| Synaptic Vesicles | 2 | 1996 | 32 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1219 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 3092 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1019 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2020 | 584 | 0.070 |
Why?
|
| Time Perception | 1 | 2005 | 24 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 1996 | 268 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 1996 | 242 | 0.060 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2023 | 7 | 0.060 |
Why?
|
| Vision, Monocular | 2 | 2001 | 15 | 0.060 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2022 | 9 | 0.060 |
Why?
|
| Technetium | 1 | 2022 | 29 | 0.060 |
Why?
|
| Diphosphates | 1 | 2022 | 18 | 0.060 |
Why?
|
| Brain Stem | 1 | 2003 | 165 | 0.060 |
Why?
|
| Spatial Memory | 1 | 2022 | 27 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 3990 | 0.050 |
Why?
|
| Sound | 1 | 2022 | 26 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1204 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2022 | 303 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2001 | 17 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2001 | 23 | 0.050 |
Why?
|
| Receptor, trkA | 1 | 2001 | 14 | 0.050 |
Why?
|
| Speech | 1 | 2021 | 84 | 0.050 |
Why?
|
| Mental Recall | 1 | 2022 | 159 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2023 | 751 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 4213 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2000 | 81 | 0.050 |
Why?
|
| Psychosurgery | 1 | 2020 | 13 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2023 | 839 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2000 | 171 | 0.040 |
Why?
|
| Ferrets | 1 | 1999 | 47 | 0.040 |
Why?
|
| Pneumonia | 1 | 2020 | 179 | 0.040 |
Why?
|
| Neurophysiological Monitoring | 1 | 2018 | 11 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 300 | 0.040 |
Why?
|
| Polysomnography | 1 | 2018 | 151 | 0.040 |
Why?
|
| Carboxy-Lyases | 1 | 2018 | 22 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 66 | 0.040 |
Why?
|
| Posture | 1 | 2017 | 125 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 14 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 110 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1996 | 34 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2018 | 267 | 0.040 |
Why?
|
| Neuropathology | 1 | 2016 | 3 | 0.040 |
Why?
|
| Prevalence | 1 | 2020 | 1239 | 0.040 |
Why?
|
| Personality | 1 | 2018 | 134 | 0.040 |
Why?
|
| Ambystoma mexicanum | 1 | 1996 | 13 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2000 | 1078 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 2016 | 56 | 0.030 |
Why?
|
| Membranes | 1 | 1996 | 36 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 502 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 310 | 0.030 |
Why?
|
| Rana pipiens | 1 | 1994 | 11 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1994 | 130 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1994 | 144 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2011 | 347 | 0.030 |
Why?
|
| Otolithic Membrane | 1 | 1993 | 12 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1994 | 115 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1538 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 70 | 0.030 |
Why?
|
| Algorithms | 1 | 2000 | 1830 | 0.030 |
Why?
|
| Electroporation | 1 | 2012 | 55 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2705 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1577 | 0.030 |
Why?
|
| Oxygen | 1 | 2016 | 726 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 3968 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2012 | 192 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 152 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 193 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6509 | 0.020 |
Why?
|
| Nerve Net | 1 | 2011 | 366 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 2894 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2001 | 50 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2001 | 6 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2001 | 19 | 0.010 |
Why?
|
| Axonal Transport | 1 | 2001 | 31 | 0.010 |
Why?
|
| Blindness | 1 | 2001 | 41 | 0.010 |
Why?
|
| Cell Count | 1 | 2001 | 195 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1753 | 0.010 |
Why?
|
| Mathematics | 1 | 1993 | 190 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 503 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 1993 | 457 | 0.010 |
Why?
|